GV (Google Ventures)

Activity from announced rounds

Activity in this selectionUnited States · Oct 20, 2026 · Sep 21, 2026

GV invests in technology and life-science companies, including AI applications, developer tools, cybersecurity, computing infrastructure and healthcare.

Its AI interests span the stack: new computing systems and inference infrastructure, tools for developers, software for professional workflows and applications in drug discovery and patient care. This gives both infrastructure founders and application builders a route to a specialist investment team.

GV developed the design sprint, a five-day process that takes a business question through problem definition, prototyping and customer testing. Its published sprint materials help teams test demand and product decisions before committing to a full launch.

Sources
Rounds participated in
4
Confirmed lead rounds
0
All roles disclosed
New companies
3
First participation on record · 1 follow-on
Funding in participating rounds
$728.5M
4 disclosed · full round size, not this investor’s share

By stage

Series A1
Series B1
Series C+1
Undisclosed1

By primary sector

AI1
Biotech1
Cybersecurity1
Healthtech1

By country

United States4

Rounds

4 in this selection
Estuary Biotherapeutics

Estuary Biotherapeutics develops locally delivered gene therapies for patients with inherited polycystic kidney disease.

$93MSeries A
Participant
Allara

Virtual care for women with hormonal, metabolic and reproductive health needs.

$30MFunding
Participant
Armadin

Armadin develops AI agents that test attack paths across enterprise systems and show defenders how connected weaknesses could be exploited.

$255.5MSeries B
Participant
Snorkel AI

Snorkel AI helps enterprises build expert-curated training data and benchmarks for advanced AI models and agents.

$350MSeries E
Participant